Analytical Data
-
Gene name
RARS
- Application
-
Alternative Names
ArgRS; DALRD1; Arginine tRNA Ligase 1,Cytoplasmic
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P54136
-
Expression Region
Met1~Pro146
-
Molecular Weight
20kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Recombinant proteins, particularly RARS (Arginyl-tRNA Synthetase), have garnered significant attention in the fields of molecular biology and biotechnology due to their critical role in protein synthesis and cellular function. RARS is an essential enzyme that catalyzes the attachment of arginine to its corresponding tRNA, a crucial step in translating mRNA into functional proteins. Abnormalities in RARS have been associated with various diseases, including neurodegenerative disorders and certain cancers, highlighting its importance in maintaining cellular homeostasis. The production of RARS as a recombinant protein allows for detailed structural and functional studies, providing insights into its enzymatic mechanisms and interactions with other cellular components. Furthermore, understanding RARS's role in disease can pave the way for potential therapeutic applications, including the development of novel strategies to target dysregulated protein synthesis pathways. Advances in recombinant DNA technology have facilitated the efficient expression and purification of RARS, enabling researchers to explore its biological significance and potential utility in biomarker discovery and drug development. Through these efforts, RARS stands as a key focus within the broader context of proteomics and translational medicine, underscoring the importance of recombinant proteins in elucidating fundamental biological processes and their implications for human health.
